Cargando…
BRM270 targets cancer stem cells and augments chemo-sensitivity in cancer
Over the past decade, a number of studies have demonstrated the resistance of cancer cells to conventional drugs and have recognized this as a major challenge in cancer therapy. While attempting to understand the underlying mechanisms of chemoresistance, several studies have suggested that the prese...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
D.A. Spandidos
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7439126/ https://www.ncbi.nlm.nih.gov/pubmed/32831922 http://dx.doi.org/10.3892/ol.2020.11964 |